Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Cyanate Inhibition of Erythrocyte Glucose-6-phosphate Dehydrogenase

Abstract

IT has been suggested that cyanate (CNO) may be useful as a therapeutic agent in the prevention of occlusive sickle cell crises1. Cyanate irreversibly carbamylates the N-terminal amino (NH2) groups of proteins and the free epsilon −NH2 groups of lysine2. Carbamylation of the terminal valine residue of sickle haemoglobin is thought to be responsible for preventing affected red blood cells (RBCs) from sickling when they are deoxygenated1. Sickle cell erythrocytes incubated with 50 mM cyanate for 90 min in vitro reportedly have an increased survival when they are radiolabelled and reinfused into the donor3. This report describes a possible side-effect of RBCs treated in vitro with sodium cyanate in similar experimental conditions: there is irreversible inactivation of the enzyme glucose-6-phosphate dehydrogenase (G6PD).

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Cerami, A., and Manning, J. M., Proc. US Nat. Acad. Sci., 65, 1180 (1971).

    Article  ADS  Google Scholar 

  2. Stark, G. R., Stein, W. H., and Moore, S., J. Biol. Chem., 235, 3177 (1960).

    CAS  Google Scholar 

  3. Gilette, P. N., Manning, J. M., and Cerami, A., Proc. US Nat. Acad. Sci., 68, 2791 (1971).

    Article  ADS  Google Scholar 

  4. Beutler, E., Red Cell Metabolism: A Manual of Biochemical Methods, 62 (Grime and Stratton, 1971).

    Google Scholar 

  5. Berry, D. H., and Hochstein, P., Biochem. Med., 4, 317 (1970).

    Article  CAS  Google Scholar 

  6. Cahill, G. F., Hastings, jun., A. B., Ashmore, J., and Zottu, S. J., J. Biol. Chem., 230, 125 (1958).

    CAS  PubMed  Google Scholar 

  7. Szeinberg, Z., and Marks, P. A., J. Clin. Invest., 40, 914 (1961).

    Article  CAS  Google Scholar 

  8. Srivastava, S. K., and Beutler, E., Biochem. J., 114, 833 (1969).

    Article  CAS  Google Scholar 

  9. Stark, G. M., J. Biol. Chem., 239, 1411 (1964).

    CAS  PubMed  Google Scholar 

  10. Kirkman, H. N., McCurdy, P. R., and Naiman, J. L., Human Genetics, 29, Cold Spring Harbor Symp. Quant. Biol., 391 (1964).

    CAS  Google Scholar 

  11. Sluyterman, A., Biochim. Biophys. Acta, 139, 439 (1967).

    Article  CAS  Google Scholar 

  12. Jacob, H. S., and Jandl, J. H., J. Biol. Chem., 241, 4243 (1966).

    CAS  PubMed  Google Scholar 

  13. Naylor, J., Rosenthal, I., Grossman, A., Schulman, I., and Hsia, D. Y.-Y., Pediatrics, 26, 285 (1960).

    CAS  PubMed  Google Scholar 

  14. Yoshida, A., Stamatoyannopoulos, G., and Motulsky, A. G., Science, 155, 97 (1967).

    Article  ADS  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

GLADER, B., CONRAD, M. Cyanate Inhibition of Erythrocyte Glucose-6-phosphate Dehydrogenase. Nature 237, 336–338 (1972). https://doi.org/10.1038/237336a0

Download citation

  • Received:

  • Revised:

  • Issue date:

  • DOI: https://doi.org/10.1038/237336a0

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing